NeoGenomics Laboratories is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and researchers globally. They specialize in providing comprehensive genetic and molecular testing critical for cancer diagnosis, prognosis, treatment selection, and clinical trial support. Their mission is to improve patient care and advance cancer research by delivering high-quality, innovative testing solutions and data insights.
Serves as the global corporate headquarters, housing executive leadership, administrative functions, advanced diagnostic laboratories, and research and development facilities. It's a central site for strategic decision-making and innovation.
The facility is a state-of-the-art, 150,000 square foot complex consolidating laboratory and corporate operations, designed to foster collaboration and efficiency. It includes advanced lab spaces for molecular, cytogenetic, and immuno-oncology testing.
The work culture at NeoGenomics HQ emphasizes innovation, scientific excellence, collaboration, and a strong patient-first mentality. Employees are often driven by the mission to fight cancer and improve patient outcomes, contributing to a purposeful environment.
The Fort Myers headquarters is significant as it represents NeoGenomics' commitment to growth, technological advancement, and providing comprehensive cancer diagnostic services. It centralizes key operations, enhancing their ability to serve clients and partners effectively.
NeoGenomics Laboratories supports cancer diagnostics and pharmaceutical research globally. Key functions supported internationally include clinical diagnostic testing in multiple US locations, and specialized pharma services (including biomarker development, clinical trial testing, and data analysis) through laboratories and offices in the US, Europe (UK, Switzerland), and Asia-Pacific (Singapore, China operations through partnerships/subsidiaries). This global footprint enables them to serve a diverse client base of oncologists, hospitals, and biopharmaceutical companies worldwide, supporting both patient care and the development of new cancer therapies.
9490 NeoGenomics Way
Fort Myers
Florida
USA
Address: 31 Columbia, Aliso Viejo, CA 92656
Provides comprehensive diagnostic testing services to oncologists and pathologists in the region, supporting patient care with timely and accurate results.
Address: 7256 S. Sam Houston Pkwy W, Suite 300, Houston, TX 77085
Supports oncological diagnostics for patients and clinicians in the Southern and Central United States, contributing to faster turnaround times for critical test results.
Address: The Maurice Wilkes Building, St John's Innovation Park, Cowley Rd, Cambridge CB4 0DS, UK
Serves the European biopharma industry by providing specialized laboratory services for oncology drug development and clinical trials.
Address: A-One Business Center, Route de l'Etraz, Z.A. La Pièce 1, Batiment A1, 1180 Rolle, Switzerland
Strategic hub for expanding Pharma Services and coordinating clinical trial support across the EMEA region.
Address: 18 Gul Crescent, Singapore 629527
Facilitates oncology research and drug development for pharma partners operating in the APAC market, providing localized lab support.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NeoGenomics Laboratories' leadership includes:
NeoGenomics Laboratories has been backed by several prominent investors over the years, including:
NeoGenomics has actively strengthened its executive leadership over the past 12-15 months with several key appointments in finance, operations, diagnostics, and scientific leadership, alongside a planned retirement. These changes aim to drive growth and innovation in both clinical and pharma services.
Discover the tools NeoGenomics Laboratories uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NeoGenomics Laboratories likely utilizes common corporate email formats. Based on industry patterns, the most probable format is combining the first initial with the last name, or first name and last name separated by a dot.
A common format is [first_initial][last]@neogenomics.com or [first].[last]@neogenomics.com
Format
jsmith@neogenomics.com
Example
75%
Success rate
NeoGenomics IR • February 27, 2024
NeoGenomics announced its financial performance for Q4 and full year 2023, highlighting revenue growth and progress in its strategic initiatives, including advanced diagnostics and pharma services....more
NeoGenomics IR • January 8, 2024
NeoGenomics announced inducement grants to new employees, including Melody Harris, its new Chief People and Operations Officer, as part of their employment commencement....more
NeoGenomics IR • November 29, 2023
NeoGenomics announced the appointments of Melody Harris as Chief People and Operations Officer and Ali Tafreshi, Ph.D., as Chief Scientific Officer, and the promotion of Warren Stone, M.D., to President, Clinical Services Division....more
BioPharma Reporter • October 10, 2023
NeoGenomics announced the opening of a new, state-of-the-art pharma services laboratory in Singapore to enhance its support for biopharmaceutical clients in the Asia-Pacific (APAC) region....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NeoGenomics Laboratories, are just a search away.